Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)

Market Cap	695.00M
Revenue (ttm)	43.46M
Net Income (ttm)	5.34M
Shares Out	250.00M
EPS (ttm)	0.02
PE Ratio	130.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,150,151
Average Volume	4,327,078
Open	2.820
Previous Close	2.820
Day's Range	2.780 - 2.840
52-Week Range	1.070 - 4.900
Beta	0.49
RSI	36.75
Earnings Date	Nov 13, 2025

About EGX:SIPC

Sabaa International Company for Pharmaceutical and Chemical Industry engages in the manufacture and sale of generic medicines in Egypt. It provides hard gelatin capsules, such as Acitretin; film coated tablets, including Saboctic, Topiramate, and Tolterodine; and tablets, such as Claudol and Flamogen E.C.T. The company also offers OTCs, food supplements, and veterinary products, as well as medicine trials services. The company was founded in 2000 and is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 165
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: SIPC